Carnival Corp. : “No, too soon, too soon. This one’s Norwegian. He’s the one with the best record and the best situation, so maybe we can get down to Carnival later.”
Fulgent Genetics: “This title is a mystery to me. It’s a pretty good company. I think it’s okay to own it. I think it’s a very good company.”
Canadian Pacific: “You should like the company. This is a rail that has come down so far, that I think you need to buy it if you think there is a chance that the economy will rebound again, and I think it will.
Cassava Science: “All I know is that the SEC, according to Dow Jones, is investigating the company. Until I know more, I will refrain from saying anything on cassava. ”
Insmed: “Pure [speculative stock]. Pure specification. Nothing beyond specification. Losing a lot of money. Just a specification and no more than that. ”
Decarbonization Plus Acquisition Corp III: “Look, I liked that. I must tell you that these are speculative stocks. this.”
Register now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.